208 related articles for article (PubMed ID: 35901978)
1. MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges.
Chetty IJ; Doemer AJ; Dolan JL; Kim JP; Cunningham JM; Dragovic J; Feldman A; Walker EM; Elshaikh M; Adil K; Movsas B; Parikh PJ
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):950-967. PubMed ID: 35901978
[TBL] [Abstract][Full Text] [Related]
2. Technical Radiotherapy Advances - The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation.
Gough J; Hall W; Good J; Nash A; Aitken K
Clin Oncol (R Coll Radiol); 2022 May; 34(5):301-312. PubMed ID: 35305888
[TBL] [Abstract][Full Text] [Related]
3. Medical physics challenges in clinical MR-guided radiotherapy.
Kurz C; Buizza G; Landry G; Kamp F; Rabe M; Paganelli C; Baroni G; Reiner M; Keall PJ; van den Berg CAT; Riboldi M
Radiat Oncol; 2020 May; 15(1):93. PubMed ID: 32370788
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
[TBL] [Abstract][Full Text] [Related]
5. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
[TBL] [Abstract][Full Text] [Related]
6. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future Directions.
Bryant JM; Doniparthi A; Weygand J; Cruz-Chamorro R; Oraiqat IM; Andreozzi J; Graham J; Redler G; Latifi K; Feygelman V; Rosenberg SA; Yu HM; Oliver DE
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958374
[TBL] [Abstract][Full Text] [Related]
8. First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany.
Klüter S; Katayama S; Spindeldreier CK; Koerber SA; Major G; Alber M; Akbaba S; Debus J; Hörner-Rieber J
Strahlenther Onkol; 2020 Aug; 196(8):691-698. PubMed ID: 32002567
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance-guided radiation therapy: A review.
Chin S; Eccles CL; McWilliam A; Chuter R; Walker E; Whitehurst P; Berresford J; Van Herk M; Hoskin PJ; Choudhury A
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):163-177. PubMed ID: 31646742
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of MR-Linac in tumor radiotherapy: a systematic review.
Liu X; Li Z; Yin Y
Radiat Oncol; 2023 Mar; 18(1):52. PubMed ID: 36918884
[TBL] [Abstract][Full Text] [Related]
11. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
[TBL] [Abstract][Full Text] [Related]
12. Intrafraction Motion Management With MR-Guided Radiation Therapy.
Fast MF; Cao M; Parikh P; Sonke JJ
Semin Radiat Oncol; 2024 Jan; 34(1):92-106. PubMed ID: 38105098
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance-guided radiotherapy feasibility in elderly cancer patients: proposal of the MASTER scoring system.
Boldrini L; Colloca GF; Villani E; Chiloiro G; Bellieni A; Manfrida S; Cellini F; Gambacorta MA; Valentini V
Tumori; 2021 Feb; 107(1):26-31. PubMed ID: 32410505
[TBL] [Abstract][Full Text] [Related]
14. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
[TBL] [Abstract][Full Text] [Related]
15. Time-Driven Activity-Based Costing Comparison of CT-Guided Versus MR-Guided SBRT.
Parikh NR; Lee PP; Raman SS; Cao M; Lamb J; Tyran M; Chin W; Gilchrist T; Agazaryan N; Mittauer K; Steinberg ML; Raldow AC
JCO Oncol Pract; 2020 Nov; 16(11):e1378-e1385. PubMed ID: 32539652
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.
Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J
Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446
[TBL] [Abstract][Full Text] [Related]
17. MOSFET dosimeter characterization in MR-guided radiation therapy (MRgRT) Linac.
Yadav P; Hallil A; Tewatia D; Dunkerley DAP; Paliwal B
J Appl Clin Med Phys; 2020 Jan; 21(1):127-135. PubMed ID: 31854078
[TBL] [Abstract][Full Text] [Related]
18. Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer.
Henke LE; Stanley JA; Robinson C; Srivastava A; Contreras JA; Curcuru A; Green OL; Massad LS; Kuroki L; Fuh K; Hagemann A; Mutch D; McCourt C; Thaker P; Powell M; Markovina S; Grigsby PW; Schwarz JK; Chundury A
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):379-389. PubMed ID: 34474109
[TBL] [Abstract][Full Text] [Related]
19. Adoption of Hybrid MRI-Linac Systems for the Treatment of Brain Tumors: A Systematic Review of the Current Literature Regarding Clinical and Technical Features.
Guerini AE; Nici S; Magrini SM; Riga S; Toraci C; Pegurri L; Facheris G; Cozzaglio C; Farina D; Liserre R; Gasparotti R; Ravanelli M; Rondi P; Spiazzi L; Buglione M
Technol Cancer Res Treat; 2023; 22():15330338231199286. PubMed ID: 37774771
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric feasibility of hippocampal avoidance whole brain radiotherapy with an MRI-guided linear accelerator.
Graham JA; Redler G; Delozier KB; Yu HM; Oliver DE; Rosenberg SA
J Appl Clin Med Phys; 2022 Jun; 23(6):e13587. PubMed ID: 35344266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]